Terms : Hide Images
| 6617234644 | alopecia | hair loss | 0 | |
| 6617236327 | anaplasi | pattern of growth in which cells lack normal characteristics and differ in shape and organization with respect to their cells of origin | 1 | |
| 6617239095 | angiogenesis | growth of new blood vessels that allows cancer cells to grow | 2 | |
| 6617241345 | apoptosis | programmed cell death | 3 | |
| 6617243361 | benign | not cancerous; benign tumors may grow but are unable to spread to other organs or body parts | 4 | |
| 6617244897 | BRM therapy | the use of agents or treatment methods that can alter the immunologic relationship between the tumor and the host to provide a therapeutic benefit | 5 | |
| 6617247712 | biopsy | a diagnostic procedure in which a small sample of tissue is removed and examined microscopically to detect malignant cells | 6 | |
| 6617250023 | brachytherapy | delivery of radiation therapy through internal implants | 7 | |
| 6617252530 | cancer | a disease process whereby cells proliferate abnormally, ignoring growth-regulating signals in the environment surrounding the cells | 8 | |
| 6617255443 | carcinogenesis | process of transforming normal cells into malignant cells | 9 | |
| 6617261219 | carcinogens | chemicals, physical factors, and other agents that cause cancer | 10 | |
| 6617263392 | chemotherapy | the use of medications to kill tumor cells by interfering with cellular functions and reproduction | 11 | |
| 6617265248 | control | containment of the growth of cancer cells | 12 | |
| 6617266738 | cure | prolonged survival and disappearance of all evidence of disease so that the patient has the same life expectancy as anyone else in his or her age group | 13 | |
| 6617269143 | cytokines | substances produced primarily by cells of the immune system to enhance production and functioning of components of the immune system | 14 | |
| 6617271686 | extravasation | leakage of medication from the veins into the subcutaneous tissues | 15 | |
| 6617277270 | grading | identification of the type of tissue from which the tumor originated and the degree to which the tumor cells retain the functional and structural characteristics of the tissue of origin | 16 | |
| 6617278497 | GVHD | an immune response initiated by T lymphocytes of donor tissue against the recipient's tissues (skin, gastrointestinal tract, liver); an undesirable response | 17 | |
| 6617282430 | graft-versus-tumor effect | the donor cell response against the malignancy; a desirable response | 18 | |
| 6617284496 | malignant | having cells or processes that are characteristic of cancer | 19 | |
| 6617286823 | mestasasis | spread of cancer cells from the primary tumor to distant sites | 20 | |
| 6617291082 | mucositis | inflammation of the lining of the gastrointestinal tract often associated with cancer therapies | 21 | |
| 6617293771 | myelosuppression | suppression of the blood cell-producing function of the bone marrow | 22 | |
| 6617295439 | nadir | lowest point of white blood cell depression after therapy that has toxic effects on the bone marrow | 23 | |
| 6617297567 | neoplasia | uncontrolled cell growth that follows no physiologic demand | 24 | |
| 6617299624 | neutropenia | abnormally low absolute neutrophil count | 25 | |
| 6617301397 | oncology | field or study of cancer | 26 | |
| 6617303181 | palliation | relief of symptoms and promotion of comfort and quality of life | 27 | |
| 6617305164 | radiation therapy | the use of ionizing radiation to kill malignant cells | 28 | |
| 6617306917 | staging | process of determining the extent of disease, including tumor size and spread or metastasis to distant sites | 29 | |
| 6617310584 | stomatitis | inflammation of the oral tissues, often associated with some chemotherapeutic agents and radiation therapy to the head and neck region | 30 | |
| 6617312210 | targeted therapies | cancer treatments that seek to minimize the negative effects on healthy tissues by disrupting specific cancer cell functions, such as malignant transformation, communication pathways, processes for growth and metastasis, and genetic coding | 31 | |
| 6617317506 | thrombocytopenia | decrease in the number of circulating platelets; associated with the potential for bleeding | 32 | |
| 6617319748 | TSA | protein on the membrane of cancer cells that distinguishes the malignant cell from a benign cell of the same tissue type | 33 | |
| 6617338260 | vesicant | substance that can cause tissue necrosis and damage | 34 | |
| 6617340622 | xerostomia | dry oral cavity resulting from decreased function of salivary glands | 35 |
